Volume | 1,039,920 |
|
|||||
News | (1) | ||||||
Day High | 52.00 | Low High |
|||||
Day Low | 50.25 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Twist Bioscience Corporation | TWST | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
51.84 | 50.25 | 52.00 | 50.46 | 53.00 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
21,601 | 1,039,920 | US$ 50.96 | US$ 52,995,311 | - | 14.42 - 54.1333 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
17:11:40 | 1 | US$ 50.56 | USD |
Twist Bioscience (TWST) Options Flow Summary
Twist Bioscience Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
2.92B | 57.82M | - | 251.02M | -204.62M | -3.54 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Twist Bioscience News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TWST Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 41.24 | 54.1333 | 39.60 | 48.33 | 1,674,398 | 9.22 | 22.36% |
1 Month | 43.36 | 54.1333 | 39.60 | 46.10 | 1,120,972 | 7.10 | 16.37% |
3 Months | 34.41 | 54.1333 | 27.41 | 38.79 | 1,036,663 | 16.05 | 46.64% |
6 Months | 26.10 | 54.1333 | 24.8101 | 36.96 | 1,112,171 | 24.36 | 93.33% |
1 Year | 17.06 | 54.1333 | 14.42 | 28.89 | 1,091,311 | 33.40 | 195.78% |
3 Years | 96.34 | 139.99 | 11.46 | 38.09 | 1,005,368 | -45.88 | -47.62% |
5 Years | 25.84 | 214.07 | 11.46 | 50.17 | 826,123 | 24.62 | 95.28% |
Twist Bioscience Description
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States. |